when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Oncology · news · pharmadog

← back to Oncology

News · Oncology

1,499 stories

Jul 2, 26STAT+: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrongstat

Jul 2, 26STAT+: A year after distressed buyout, what’s become of Bluebird Bio?stat

Jul 1, 26Statins and blood pressure drugs changing health risks of obesity, study suggestsstat

Jul 1, 26FDA approves Orca Bio’s cell therapy to improve transplant outcomesendpoints

Jul 1, 26STAT+: Synthetic biology researchers think they’ve made a cell. Is it alive?stat

Jul 1, 26Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M dealbiopharma dive

Jul 1, 26STAT+: Pharmalittle: We’re reading about Anthropic drug development goals, Trump drug plan snags, and morestat

Jul 1, 26STAT+: More signs that GLP-1s may help with peripheral artery diseasestat

Jul 1, 26Abivax shares surge as worries subside over immune drug’s cancer riskbiopharma dive

Jul 1, 26FDA says Zyn can market its pouches as safer than cigarettesstat

Jul 1, 26STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patientsstat

Jul 1, 26STAT+: Booze schmooze: The alcohol industry, frazzled by headwinds, wields its power behind the scenesstat

Jun 30, 26FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patientsfda press

Jun 30, 26Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot programbiopharma dive

Jun 30, 26AbbVie and Genmab's latest win brings Epkinly closer to label expansionendpoints

Jun 30, 26Abivax aims to set cancer concerns with ulcerative colitis drug to restendpoints

Jun 30, 26These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.biopharma dive

Jun 30, 26Sarepta's FDA decision date; Flare gets Anna Protopapas as CEOendpoints

Jun 30, 26STAT+: FDA digital leader hints at coming AI policy updatesstat

Jun 30, 26STAT+: Pharmalittle: We’re reading about Chinese trial sites being probed, RFK Jr. and peptides, and morestat

Jun 30, 26Half of states sue over Medicaid work requirementsstat

Jun 30, 26STAT+: Abivax seeks to ease safety concerns with new data, boosting sharesstat

Jun 29, 26STAT+: AstraZeneca to pay $34 million to settle kickback charges filed by Texas attorney generalstat

Jun 29, 26FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturingfda press

Jun 29, 26John Reed on J&J’s R&D model, oncology deals and pipeline expansion potentialendpoints

Jun 29, 26Ipsen to buy blood cancer company Kartos Therapeutics for $450M upfrontendpoints

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 26, 26FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences servicesbiopharma dive

Jun 26, 26On second try, Acadia drug gets nod from European regulatorsbiopharma dive

Jun 20, 26Opinion: Why the space in ‘health care’ mattersstat

← prevpage 34 of 50next →